Trial Profile
Clinical Trials Insight: 700023499
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs Tarenflurbil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Myrexis
- 31 May 2007 New trial record.